Valeant’s New CEO Holds First Annual Meeting Since Taking Over Drug Company
LAVAL, Que. – Valeant’s new chairman and CEO will be sharing his turnaround plan directly with shareholders today at his first annual meeting since assuming leadership of the embattled drug company in late April. Joseph Papa says he has developed a stabilization plan that the Quebec-based company will pursue over the next three to six months before…
